OA10979A - Stable non-hygroscopic crystalline form of n-Än-n-(piperidin-4-yl)butanoyl)-n-ethylglycylÜcompounds - Google Patents

Stable non-hygroscopic crystalline form of n-Än-n-(piperidin-4-yl)butanoyl)-n-ethylglycylÜcompounds Download PDF

Info

Publication number
OA10979A
OA10979A OA9900037A OA9900037A OA10979A OA 10979 A OA10979 A OA 10979A OA 9900037 A OA9900037 A OA 9900037A OA 9900037 A OA9900037 A OA 9900037A OA 10979 A OA10979 A OA 10979A
Authority
OA
OAPI
Prior art keywords
compound
acid
alkyl
aryl
aralkyl
Prior art date
Application number
OA9900037A
Other languages
English (en)
Inventor
Zofia J Chrzan
James J Mencel
David Toledo-Valasquez
Vincent Windisch
Rick G Woodward
Diane C Salazar
Narasimba M Vemuri
Anthony J Gardetto
Matthew R Powers
Gregory G Kubiak
Robert C Liu
Benoit J Vanasse
James P Sherbine
Water Rodriguez
Adam W Sledeski
Original Assignee
Rhone Poulenc Rorer Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Pharma filed Critical Rhone Poulenc Rorer Pharma
Publication of OA10979A publication Critical patent/OA10979A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
OA9900037A 1996-08-21 1999-02-19 Stable non-hygroscopic crystalline form of n-Än-n-(piperidin-4-yl)butanoyl)-n-ethylglycylÜcompounds OA10979A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2428496P 1996-08-21 1996-08-21

Publications (1)

Publication Number Publication Date
OA10979A true OA10979A (en) 2001-11-01

Family

ID=21819807

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9900037A OA10979A (en) 1996-08-21 1999-02-19 Stable non-hygroscopic crystalline form of n-Än-n-(piperidin-4-yl)butanoyl)-n-ethylglycylÜcompounds

Country Status (20)

Country Link
US (2) US6153588A (zh)
EP (1) EP0923553B1 (zh)
JP (1) JP4008499B2 (zh)
KR (1) KR20000068229A (zh)
CN (2) CN1231659A (zh)
AP (1) AP9901462A0 (zh)
AT (1) ATE390438T1 (zh)
AU (1) AU733591B2 (zh)
BG (1) BG63538B1 (zh)
BR (1) BR9711340A (zh)
CA (1) CA2263647C (zh)
DE (1) DE69738601T2 (zh)
EA (1) EA001362B1 (zh)
IL (1) IL128561A0 (zh)
NO (1) NO990721L (zh)
OA (1) OA10979A (zh)
PL (1) PL331772A1 (zh)
SK (1) SK21999A3 (zh)
WO (1) WO1998007696A1 (zh)
ZA (1) ZA977510B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998007696A1 (en) * 1996-08-21 1998-02-26 Rhone-Poulenc Rorer Pharmaceuticals Inc. Stable non-hygroscopic crystalline form of n-[n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds
WO1999019294A1 (en) * 1997-05-14 1999-04-22 Aventis Pharmaceuticals Products Inc. Legal/Patents Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides
CN1278791A (zh) * 1997-10-10 2001-01-03 阿温蒂斯药物制品公司 制造氮杂环烷基烷酰基假四肽的方法
WO2000040601A1 (en) * 1998-12-30 2000-07-13 Aventis Pharmaceuticals Products Inc. Process for preparing a stable non-hygroscopic crystalline n-[n-[n- piperdin- 4-yl)butanoyl)- n.ethylglycyl]- (l)-aspartyl] -ss-cyclohexylalanine amide
US20050238834A1 (en) * 2004-04-21 2005-10-27 Eastman Kodak Company High modulus label with compliant carrier sheet
US8021679B2 (en) 2005-08-25 2011-09-20 Medtronic Vascular, Inc Nitric oxide-releasing biodegradable polymers useful as medical devices and coatings therefore
US8241619B2 (en) 2006-05-15 2012-08-14 Medtronic Vascular, Inc. Hindered amine nitric oxide donating polymers for coating medical devices
US7811600B2 (en) * 2007-03-08 2010-10-12 Medtronic Vascular, Inc. Nitric oxide donating medical devices and methods of making same
US8273828B2 (en) * 2007-07-24 2012-09-25 Medtronic Vascular, Inc. Methods for introducing reactive secondary amines pendant to polymers backbones that are useful for diazeniumdiolation
US20090222088A1 (en) * 2008-02-29 2009-09-03 Medtronic Vascular, Inc. Secondary Amine Containing Nitric Oxide Releasing Polymer Composition
US20090232868A1 (en) * 2008-03-17 2009-09-17 Medtronic Vascular, Inc. Nitric Oxide Releasing Polymer Composition
US20090232863A1 (en) * 2008-03-17 2009-09-17 Medtronic Vascular, Inc. Biodegradable Carbon Diazeniumdiolate Based Nitric Oxide Donating Polymers
US8158187B2 (en) * 2008-12-19 2012-04-17 Medtronic Vascular, Inc. Dry diazeniumdiolation methods for producing nitric oxide releasing medical devices
US8709465B2 (en) * 2009-04-13 2014-04-29 Medtronic Vascular, Inc. Diazeniumdiolated phosphorylcholine polymers for nitric oxide release
US9704557B2 (en) * 2013-09-25 2017-07-11 Qualcomm Incorporated Method and apparatus for storing retention time profile information based on retention time and temperature
CN108697770B (zh) 2015-12-21 2023-08-01 得克萨斯技术大学联合体 用于溶液相gap肽合成的系统和方法
WO2019217116A1 (en) * 2018-05-06 2019-11-14 Gap Peptides Llc Method for solution-phase peptide synthesis
EP3917937A4 (en) 2019-02-01 2022-11-23 Sederma SYNTHETIC STRATEGY FOR A SPLIT PROTECTION GROUP

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
US4992463A (en) * 1988-07-20 1991-02-12 Monsanto Company Thienyl peptide mimetic compounds which are useful in inhibiting platelet aggregation
US4952562A (en) * 1989-09-29 1990-08-28 Rorer Pharmaceutical Corporation Anti-thrombotic peptides and pseudopeptides
US5332726A (en) * 1989-09-29 1994-07-26 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic peptides and pseudopeptides
US5064814A (en) * 1990-04-05 1991-11-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Anti-thrombotic peptide and pseudopeptide derivatives
NZ239876A (en) * 1990-09-27 1993-12-23 Merck & Co Inc Glycyl-b-alanine derivatives and pharmaceutical compositions thereof.
US5264420A (en) 1990-09-27 1993-11-23 Merck & Co., Inc. Fibrinogen receptor antagonists
US5218138A (en) 1992-09-02 1993-06-08 Rhone-Poulenc Rorer Pharmaceuticals Inc. Stereoselective reduction of 3-hydroxyket-1-ones to 1,3-syn-dihydroxylated compounds
US5340798A (en) * 1992-10-14 1994-08-23 Merck & Co., Inc. Fibrinogen receptor antagonists
US5607948A (en) * 1993-06-30 1997-03-04 Sumitomo Pharmaceuticals Co., Ltd. Dipiperidine derivatives
US5780590A (en) * 1993-10-15 1998-07-14 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
EP0812205B1 (en) * 1993-10-15 2001-03-14 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
WO1995011228A1 (fr) * 1993-10-19 1995-04-27 Sumitomo Pharmaceuticals Co., Ltd. Derive d'acide 2,3-diaminopropionique
WO1998007696A1 (en) * 1996-08-21 1998-02-26 Rhone-Poulenc Rorer Pharmaceuticals Inc. Stable non-hygroscopic crystalline form of n-[n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds
CN1278791A (zh) * 1997-10-10 2001-01-03 阿温蒂斯药物制品公司 制造氮杂环烷基烷酰基假四肽的方法

Also Published As

Publication number Publication date
BG63538B1 (bg) 2002-04-30
EP0923553B1 (en) 2008-03-26
IL128561A0 (en) 2000-01-31
ZA977510B (en) 1998-05-21
AP9901462A0 (en) 1999-03-31
EP0923553A1 (en) 1999-06-23
CN1491942A (zh) 2004-04-28
WO1998007696A1 (en) 1998-02-26
EA001362B1 (ru) 2001-02-26
BG103225A (en) 2000-01-31
SK21999A3 (en) 2000-02-14
NO990721D0 (no) 1999-02-16
US6753409B1 (en) 2004-06-22
DE69738601T2 (de) 2009-04-30
EP0923553A4 (en) 1999-12-08
BR9711340A (pt) 1999-08-17
CA2263647A1 (en) 1998-02-26
KR20000068229A (ko) 2000-11-25
CA2263647C (en) 2011-02-15
JP2000517305A (ja) 2000-12-26
PL331772A1 (en) 1999-08-02
EA199900217A1 (ru) 1999-08-26
JP4008499B2 (ja) 2007-11-14
ATE390438T1 (de) 2008-04-15
NO990721L (no) 1999-04-20
AU733591B2 (en) 2001-05-17
CN1231659A (zh) 1999-10-13
DE69738601D1 (de) 2008-05-08
US6153588A (en) 2000-11-28
AU4156397A (en) 1998-03-06

Similar Documents

Publication Publication Date Title
OA10979A (en) Stable non-hygroscopic crystalline form of n-Än-n-(piperidin-4-yl)butanoyl)-n-ethylglycylÜcompounds
US20050222395A1 (en) New peptide derivatives
JPH07121955B2 (ja) アミノ酸誘導体およびその製法
US4218474A (en) Derivatives of L- and DL-4-hydroxyphenylglycine
AP904A (en) Antithrombotic Azacycloalkylalkanoyl peptides and pseudopeptides.
JPH0742309B2 (ja) チアゾリジン誘導体
US5332726A (en) Antithrombotic peptides and pseudopeptides
AU703854B2 (en) Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
JPH0670023B2 (ja) チアゾリジン誘導体
JPH082791B2 (ja) 健忘症治療剤
US6797700B2 (en) Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
JPH0776211B2 (ja) ピログルタミン酸誘導体
MXPA99001773A (en) Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
MXPA99001772A (en) Stable non-hygroscopic crystalline form of n-[n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl]compounds
CZ55199A3 (cs) Stabilní, nehygroskopická krystalická forma N- [N-[N(4-piperidin-4-yl)butanoyl]-N-ethylgIycyl]ových derivátů
CZ55099A3 (cs) Antitrombotické azacykloalkylalkanoylové peptidy a pseudopeptidy
JPH082869B2 (ja) 健忘症治療剤およびプロリン誘導体
NZ299833A (en) Treating or preventing thrombosis using azacycloalkanol peptides and pseudopeptides
JPH0678242B2 (ja) プロリルエンドペプチダーゼ阻害剤